{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:15:13Z","timestamp":1786976113242,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd008994","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000}}],"reference-count":47,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008994.pub2","type":"journal-article","created":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T01:56:24Z","timestamp":1361584584000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Progestogens or progestogen-releasing intrauterine systems for uterine fibroids"],"prefix":"10.1002","author":[{"given":"Ussanee S","family":"Sangkomkamhang","sequence":"first","affiliation":[{"name":"Khon Kaen Hospital; Department of Obstetrics and Gynaecology; Srichan Road Maung Khon Kaen Thailand 40000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pisake","family":"Lumbiganon","sequence":"additional","affiliation":[{"name":"Khon Kaen University; Department of Obstetrics and Gynaecology, Faculty of Medicine; 123 Mitraparb Road Amphur Muang Khon Kaen Thailand 40002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malinee","family":"Laopaiboon","sequence":"additional","affiliation":[{"name":"Khon Kaen University; Department of Biostatistics and Demography, Faculty of Public Health; Khon Kaen Thailand 40002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Willem J","family":"Mol","sequence":"additional","affiliation":[{"name":"Academic Medical Centre, University of Amsterdam; Obstetrics and Gynaecology; Meibergdreef 9 PO Box 22700 Amsterdam Netherlands 1105 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,28]]},"reference":[{"key":"10.1002\/14651858.CD008994.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1469-0705.2002.00805.x","article-title":"Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy","volume":"20(4)","author":"Inki","year":"2002","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD008994.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0301-2115(99)00168-2","article-title":"Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: a multicentre randomised trial","volume":"89","author":"Verspyck","year":"2000","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/humrep\/12.3.436","article-title":"Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability","volume":"12","author":"Caird","year":"1997","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD008994.pub2-BIB0005|cit5","first-page":"1217","article-title":"An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial","volume":"76","author":"Carr","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1471-0528.2007.01545.x","article-title":"A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women","volume":"114(12)","author":"Chan","year":"2007","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26(3)","author":"Chwalisz","year":"2005","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2006.11.094","article-title":"A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata","volume":"87(6)","author":"Chwalisz","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0015-0282(16)59763-5","article-title":"A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri","volume":"49","author":"Friedman","year":"1988","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1538-7836.2006.02243.x","article-title":"The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic\/inhibitor systems in women with menorrhagia","volume":"5(1)","author":"Koh","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111(5)","author":"Levens","year":"2008","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0012|cit12","unstructured":"Magalhaes J Magalhaes LB European Journal of Contraception and Reproductive Health Care The Hague Netherlands 2010"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0301-2115(01)00588-7","article-title":"Effect of different doses of progestin on uterine leiomyomas in postmenopausal women","volume":"102(2)","author":"Palomba","year":"2002","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD008994.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ajog.2009.10.863","article-title":"Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications","volume":"May;202","author":"Rodriguez","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD008994.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0015-0282(16)57729-2","article-title":"Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri","volume":"64","author":"Scialli","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD008994.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3329\/bjog.v23i1.3054","article-title":"Levonorgestrel intrauterine system Mirena: An update","volume":"23","author":"Siddiqui","year":"2008","journal-title":"Bangladesh Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000080932","article-title":"The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial","volume":"59(1)","author":"Soysal","year":"2005","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/oxfordjournals.humrep.a137643","article-title":"Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids","volume":"7","author":"West","year":"1992","journal-title":"Human Reproduction"},{"issue":"12","key":"10.1002\/14651858.CD008994.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2008-1104","article-title":"Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy","volume":"Dec;93","author":"Wilkens","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0030-1251483","article-title":"Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth","volume":"May;28","author":"Yoshida","year":"2010","journal-title":"Seminars in Reproductive Medicine"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0002-9378(93)90293-R","article-title":"Expression of connexin-43 in human myometrium and leiomyoma","volume":"169","author":"Andersen","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0022|cit22","first-page":"225","article-title":"Factors in fibroid growth","volume":"12","author":"Andersen","year":"1998","journal-title":"Bailliere's Clinical Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/j.1600-0412.2000.079003202.x","article-title":"Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyomas in a random sample of women aged 25-40 years","volume":"79","author":"Borgfeldt","year":"2000","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0024|cit24","first-page":"453","article-title":"The frequency of uterine leiomyomas","volume":"90","author":"Cramer","year":"1990","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0025|cit25","first-page":"131-8","article-title":"Treatment of uterine fibroids by embolization--advantages, disadvantages, and pitfalls","volume":"123","author":"DavidM","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0026|cit26","first-page":"629-34","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315(7109)","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0027|cit27","unstructured":"FIGO The International Federation of Gynecology and Obstetrics Internet 2001"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and pathogenesis of uterine leiomyomas: a review","volume":"111","author":"Flake","year":"2003","journal-title":"Environmental Health Perspectives"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0029|cit29","unstructured":"Higgins JPT Altman DG Sterne JC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies Cochrane Handbook for SystematicReviews of Interventions Version 5.1.0 [updated March2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD008994.pub2-BIB0030|cit30","first-page":"S130-3. Epub 20","article-title":"Progestin-releasing intrauterine systems and leiomyoma","volume":"75","author":"Kaunitz","year":"2007","journal-title":"Contraception"},{"issue":"4","key":"10.1002\/14651858.CD008994.pub2-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD008994.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-0528.1996.tb09911.x","article-title":"Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study","volume":"103","author":"Lumbiganon","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"10-11","key":"10.1002\/14651858.CD008994.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0039-128X(00)00171-9","article-title":"Effects of progesterone on uterine leiomyoma growth and apoptosis","volume":"65","author":"Maruo","year":"2000","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"59-67","DOI":"10.1016\/j.ogc.2005.12.001","article-title":"Steroid hormones and leiomyomas","volume":"33","author":"Marsh","year":"2006","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Human Reproduction Update"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD008994.pub2-BIB0036|cit36","first-page":"S99-103. Epub 2","article-title":"Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas","volume":"75","author":"Maruo","year":"2007","journal-title":"Contraception"},{"issue":"4","key":"10.1002\/14651858.CD008994.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"Okolo","year":"2008","journal-title":"Best Practice & Research. Clinical Obstetrics & Gynaecology"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD008994.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9378(95)90077-2","article-title":"Progesterone: a critical role in the pathogenesis of uterine myomas","volume":"172","author":"Rein","year":"1995 Jan","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"235-41","DOI":"10.1097\/00004347-198609000-00005","article-title":"Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices","volume":"5","author":"Silverberg","year":"1986","journal-title":"International Journal of Gynecological Pathology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0040|cit40","first-page":"55","article-title":"Successful treatment of fibroids using an intrauterine progesterone device","volume":"46","author":"Singer","year":"1994","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0041|cit41","first-page":"1221","article-title":"Intrauterine therapy with levonorgestrel-releasing IUD of women with hypermenorrhea secondary to uterine fibroids","volume":"71","author":"Starczewski","year":"2000","journal-title":"Ginekologia Polska"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"293-8","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"364-71","DOI":"10.1097\/00003081-200106000-00022","article-title":"Clinical symptomatology of uterine leiomyomas","volume":"44","author":"Stovall","year":"2001","journal-title":"Clinical Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"393-406","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Uterine myomas: an overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0045|cit45","unstructured":"Medical eligibility criteria for contraceptive use WHO. Department of Reproductive Health and Research 2004"},{"key":"10.1002\/14651858.CD008994.pub2-BIB0046|cit46","unstructured":"United Nations Population Division World Contraceptive Use 2005 wall chart. New York, NY: United Nations 2005"},{"issue":"1","key":"10.1002\/14651858.CD008994.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2010.02.011","article-title":"Intrauterine device use among women with uterine fibroids: a systematic review","volume":"82","author":"Zapata","year":"2010","journal-title":"Contraception"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008994.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008994.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:26:28Z","timestamp":1628533588000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008994.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008994.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,28]]}}}